Mackay Shields LLC’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,755
| Closed | -$754K | – | 1100 |
|
|
2021
Q1 | $754K | Hold |
7,755
| – | – | 0.01% | 1084 |
|
|
2020
Q4 | $743K | Sell |
7,755
-16,857
| -68% | -$1.62M | 0.01% | 1157 |
|
|
2020
Q3 | $2.37M | Sell |
24,612
-8,437
| -26% | -$811K | 0.02% | 711 |
|
|
2020
Q2 | $4.03M | Sell |
33,049
-8,158
| -20% | -$995K | 0.03% | 474 |
|
|
2020
Q1 | $3.57M | Buy |
+41,207
| New | +$3.57M | 0.03% | 455 |
|
|
2019
Q1 | – | Sell |
-17,772
| Closed | -$1.27M | – | 1422 |
|
|
2018
Q4 | $1.27M | Buy |
+17,772
| New | +$1.27M | 0.01% | 854 |
|